Updated Position of the Spanish Psoriasis Group (GPs) on the Use of Biosimilar Drugs in Moderate to Severe Psoriasis R. Ruiz-Villaverde, M. Galán-Gutiérrez, M. Llamas-Velasco, L. Salgado-Boquete, L. Puig, P. de la Cueva, J.M. Carrascosa

Psoriatic Patient-Reported Outcomes, Adherence, and Satisfaction J. Perales Pascual, H. Navarro Aznárez, A. López Pérez, T. Gracia-Cazaña, Y. Gilaberte Calzada, Mª R. Abad Sazatornil

Does the treatment ladder for systemic therapy in moderate to severe psoriasis only go up? The percentage of patients with severe psoriasis on biologics increases over time J.M. Carrascosa, N. Rivera, I. Garcia-Doval, G. Carretero, F. Vanaclocha, E. Daudén, F.J. Gómez-García, P. De-la-Cueva-Dobao, E. Herrera-Ceballos, I. Belinchón, M. Alsina, J.L. Sánchez-Carazo, M. Ferrán, J.L. Lopez-Estebaranz, B. Pérez-Zafrilla, M. Llamas, R. Rivera, C. Ferrándiz